Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT05921344

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05921344
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05921344. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-07-11 (actual); primary completion 2023-09-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection
Condition
Medical Device
Intervention (Device)
Multi-channel Microspatial Offset Raman Scattering Spectroscopy (mμSORS) for Noninvasive Blood Glucose Detection
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)
Collaborator
Shanghai Photonic View Technology Co., Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct05921344
Content hash
1df096b9af74f1f00ffaf5a2f50a436617a71a230cd9b865178c2e0fa30f9cf3